Sentences with phrase «aspirin reduces»

A: The evidence that aspirin reduces the incidence of colorectal cancer is now undisputed.

For example aspirin reduces the risk of stroke but does not affect the occurrence of myocardial infarction in women, while in men aspirin reduces the risk of myocardial infarction with a non-significant increase in the risk of stroke.

Although aspirin reduces the risk of major cardiovascular events by 19 per cent, a more effective antithrombotic strategy could have major benefits for the large population of patients with stable cardiovascular disease.

Not exact matches

If none of the recommendations above help, a gentle massage or an over-the-counter aspirin may help to reduce pain.

You might also want to use ibuprofen or Tylenol to help reduce inflammation and pain, but you should not use aspirin if you are breastfeeding your baby.

The Aspirin cuts down on pain as well, but also reduces inflammation, making it a good option for treating other types of aches and pains throughout your body too.

In one human study, researchers in Taiwan found that rhino horn temporarily reduced fever in children, but it was no more effective than aspirin.

Benner cautions that nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and aspirin also reduce fevers, but some NSAIDs are not safe to use during the later stages of pregnancy.

Existing recommendations for postpartum and prenatal care that may prevent recurrent hypertensive disease of pregnancy include the use of reliable contraception following delivery to prevent unintended pregnancy and taking low - dose aspirin in subsequent pregnancies to reduce recurrence risk.

«Frequent aspirin use reduces risk of cervical cancer by nearly half.»

We welcome this research which shows that taking aspirin after TIA can dramatically reduce the risk and severity of further stroke.

RAISING RISK Painkillers like this baby aspirin have been associated with reducing the risk of colorectal cancer, yet they can actually boost the risk in rare cases, a new study finds.

«Immediate aspirin after mini-stroke substantially reduces risk of major stroke: Benefits of taking aspirin immediately after minor strokes have been underestimated.»

They found that almost all of the benefit of aspirin in reducing the risk of another stroke was in the first few weeks, and that aspirin also reduced the severity of these early strokes.

After a mini-stroke, almost all of the benefit of aspirin in reducing the risk of another stroke was found to be in the first few weeks, and researchers also found that aspirin also likely reduced the severity of these early strokes.

Aspirin use was associated with a 47 % reduced risk of cervical cancer among frequent users — those who used aspirin seven or more times a week, regardless of duration — and 41 % reduced risk among long - term frequent users — those with five or more years of frequeAspirin use was associated with a 47 % reduced risk of cervical cancer among frequent users — those who used aspirin seven or more times a week, regardless of duration — and 41 % reduced risk among long - term frequent users — those with five or more years of frequeaspirin seven or more times a week, regardless of duration — and 41 % reduced risk among long - term frequent users — those with five or more years of frequent use.

Immediate treatment with aspirin can substantially reduce the risk and severity of early recurrent stroke.

Using aspirin urgently could substantially reduce the risk of major strokes in patients who have minor «warning» events, a group of European researchers has found.

On the basis of similar — though admittedly stronger — evidence, doctors already advise millions of people to take low - dose aspirin to reduce their risk of having heart attacks and strokes.

At the same time, aspirin did not reduce incidence of post-operative heart attacks and death, according to data from POISE - 2 presented at the American College of Cardiology's 63rd Annual Scientific Session.

A team of current and former Mayo Clinic researchers has discovered that aspirin use is associated with a significantly reduced risk of developing bile duct cancer, also called cholangiocarcinoma.

The results come during a time when studies investigating aspirin's anti-cancer effects have found evidence to support its benefit, beyond staving off cardiovascular disease or, in oncology, reducing the risk of colorectal cancer.

Kontos adds that a greater role for aspirin would be welcomed by many at - risk patients, as current drugs aimed at reducing risk, such as tamoxifen and raloxifene, have significant side effects and do not prevent ER - negative breast cancer.

A recent contender in the drug wars is a chemical long known to reduce blood sugar — a relative of aspirin in the chemical family of salicylates.

However, another study suggests aspirin may in fact help reduce breast tissue density, which could lead to earlier detection of some breast cancers.

Researchers at Taichung Veterans General Hospital in Taichung, Taiwan; E ‐ Da Hospital in Kaohsiung, Taiwan; Fu Jen Catholic University in New Taipei City, Taiwan; and National Taiwan University Hospital in Taipei conducted a nationwide cohort study to determine if aspirin therapy could, indeed, reduce liver cancer risk.

«However, perhaps someday a PAI - 1 inhibitor can be used in combination with other approaches such as proper diet and exercise, aspirin and cholesterol medications to prevent blood vessel blockages and reduce heart attack and stroke risk.»

Low doses of aspirin, an anti-platelet drug, have been shown to reduce the risk of some types of gastrointestinal cancers, but the process by which aspirin hampers tumor growth has been unclear.

People at risk of stroke often take aspirin to reduce their risk of having another stroke; however, a percentage of patients may be insensitive, or resistant, to aspirin, which in turn may negate the aspirin's effect of lowering stroke risk.

Aspirin therapy has been recommended to reduce subclinical atherosclerosis and cardiovascular disease outcomes, including stroke.

After a heart attack, standard practice calls for putting patients on a lifetime regimen of daily aspirin to prevent clotting and reduce the chance of another heart attack.

In the case of steroidal drugs, such as cortisol, and non-steroidal medications, such as aspirin, this is achieved by reducing inflammation.

Adding the antiplatelet drug ticagrelor to aspirin as long - term therapy after a heart attack significantly reduced the rate of subsequent death from cardiovascular causes, heart attack or stroke, with the benefit appearing to accrue for nearly three years, according to a study presented at the American College of Cardiology's 64th Annual Scientific Session.

Aspirin, which was already known to help people with heart disease, seems to work primarily by reducing inflammation.

People at high risk of cancer may soon be advised to take readily available drugs such as aspirin to reduce their chances of succumbing to one of the world's biggest killers.

Humans have reduced fevers for thousands of years; Hippocrates recommended extracts of the willow tree bark, which was later found to contain salicylic acid, better known as aspirin; Romans, Chinese, and Native Americans used other plants containing similar compounds.

The 10 - year Warfarin and Aspirin for Reduced Cardiac Ejection Fraction (WARCEF) trial is the largest randomized, double - blind comparison of aspirin and warfarin (also known by its brand name Coumadin) for heart failure, following 2,305 heart failure patients whose heart muscle pumps less oxygen - rich blood into the body, known as reduced ejection fraction, at 168 study sites in 11 countries on three contAspirin for Reduced Cardiac Ejection Fraction (WARCEF) trial is the largest randomized, double - blind comparison of aspirin and warfarin (also known by its brand name Coumadin) for heart failure, following 2,305 heart failure patients whose heart muscle pumps less oxygen - rich blood into the body, known as reduced ejection fraction, at 168 study sites in 11 countries on three contReduced Cardiac Ejection Fraction (WARCEF) trial is the largest randomized, double - blind comparison of aspirin and warfarin (also known by its brand name Coumadin) for heart failure, following 2,305 heart failure patients whose heart muscle pumps less oxygen - rich blood into the body, known as reduced ejection fraction, at 168 study sites in 11 countries on three contaspirin and warfarin (also known by its brand name Coumadin) for heart failure, following 2,305 heart failure patients whose heart muscle pumps less oxygen - rich blood into the body, known as reduced ejection fraction, at 168 study sites in 11 countries on three contreduced ejection fraction, at 168 study sites in 11 countries on three continents.

For patients with sore throat, physicians should recommend analgesic therapy such as aspirin, acetaminophen, nonsteroidal anti-inflammatory drugs, and throat lozenges, which can help reduce pain.

There are plenty of examples of drugs originally developed to treat one disease that turned out to help another: Acetylsalicylic acid (aspirin) is not just a pain killer but is also used to reduce the risk of heart attack.

Aspirin interferes with blood's ability to clot, by reducing the activity of platelets, which aggregate during clot formation.

«All patients suffering from blockage of an artery in the heart or brain should receive 325 mg regular aspirin promptly and daily aspirin thereafter to reduce their death rate as well as subsequent heart attacks and strokes,» said Hennekens.

Results of one of the largest studies of heart failure to date show that warfarin is no better than aspirin in reducing the combined risks of brain hemorrhage, stroke and death in most heart failure patients.

Aspirin's pain - reducing power comes from its ability to disrupt an enzyme in the body called cyclooxygenase, an important player in pain signaling.

The SMC hosted the Lancet for this briefing on a recent study which found that taking a daily low - dose of aspirin may significantly reduce the risk of developing several cancers.

The study also may help explain an intriguing association between aspirin and reduced rates of Alzheimer's.

Previous studies have shown that aspirin prevents cardiovascular disease and some types of cancer, particularly colorectal cancer, and seems to reduce the risk of dying from cancer.

TUESDAY, May 29, 2012 (Health.com)-- Regular aspirin use, which doctors have long recommended for heart attack and stroke prevention, also may help reduce the risk of some forms of skin cancer, a new study suggests.

It's also in the aspirin family, so it can be used to reduce inflammation or redness.

Aspirin has been shown to reduce the risk of colorectal cancer and precancerous polyps, and in a pair of studies published earlier this year, researchers found that people were less likely to develop or die from cancers — including those of the lung, prostate, and bladder — if they took aspirinAspirin has been shown to reduce the risk of colorectal cancer and precancerous polyps, and in a pair of studies published earlier this year, researchers found that people were less likely to develop or die from cancers — including those of the lung, prostate, and bladder — if they took aspirinaspirin daily.

One survey of studies comprising nearly 100,000 people found that aspirin therapy reduced the risk of cardiovascular events and stroke in women by 12 % and 17 %, respectively, but did not reduce the likelihood of a heart attack or early death.